Viva Biotech Holdings (FRA:VB0) Other Gross PPE: €0.0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:VB0 Viva Biotech Holdings FRA:VB0
43 GF Score
Price €0.16
GF Value €0.14
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Viva Biotech Holdings Other Gross PPE?

Viva Biotech Holdings FRA:VB0 +6.67% 43 Other Gross PPE is €0.0 Mil as of Jun. 2026. GuruFocus rates FRA:VB0 with a GF Score™ of 43/100 and a GF Value™ of €0.14 (Modestly Overvalued). The stock has 5 warning signs investors should review.

Viva Biotech Holdings's Other Gross PPE for the quarter that ended in Jun. 2026 was €0.0 Mil.

Viva Biotech Holdings's quarterly Other Gross PPE increased from Jun. 2025 (€0.0 Mil) to Dec. 2025 (€255.6 Mil) but then declined from Dec. 2025 (€255.6 Mil) to Jun. 2026 (€0.0 Mil).

Viva Biotech Holdings's annual Other Gross PPE increased from Dec. 2023 (€109.8 Mil) to Dec. 2024 (€124.0 Mil) but then declined from Dec. 2024 (€124.0 Mil) to Dec. 2025 (€115.5 Mil).

Viva Biotech Holdings Other Gross PPE Historical Data

* Premium members only.

The historical data trend for Viva Biotech Holdings's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Viva Biotech Holdings Other Gross PPE Chart

Viva Biotech Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Gross PPE
Get a 7-Day Free Trial Premium Member Only Premium Member Only 116.35 127.11 109.76 124.01 115.51

Viva Biotech Holdings Semi-Annual Data
Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 269.37 0.00 255.64 0.00
FRA:VB0
43GF Score
Viva Biotech Holdings FRA:VB0
Other Gross PPE is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Viva Biotech Holdings Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.

Frequently Asked Questions Learn more about Other Gross PPE →
What does a Other Gross PPE of €0.0 Mil mean?
Viva Biotech Holdings (FRA:VB0) has a Other Gross PPE of €0.0 Mil as of Jun. 2026. Other Gross PPE is property, plant and equipment recorded on a company's balance sheet that not otherwise classified. View historical data on Viva Biotech Holdings and its competitors.
Is Viva Biotech Holdings' Other Gross PPE too high?
Viva Biotech Holdings' current Other Gross PPE is €0.0 Mil. Overall, Viva Biotech Holdings has a GF Score™ of 43/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Viva Biotech Holdings' Other Gross PPE compare to VRTX and REGN?
Viva Biotech Holdings' Other Gross PPE of €0.0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Gross PPE for a Biotechnology company?
A good Other Gross PPE depends on the Biotechnology industry context. However, Other Gross PPE should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Gross PPE mean?
A high Other Gross PPE can signal that a stock is expensive relative to its fundamentals. Other Gross PPE is property, plant and equipment recorded on a company's balance sheet that not otherwise classified. View historical data on Viva Biotech Holdings and its competitors. Viva Biotech Holdings's current Other Gross PPE is €0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Viva Biotech Holdings stock overvalued right now?
Based on GuruFocus' analysis, Viva Biotech Holdings (FRA:VB0) is currently considered Modestly Overvalued. The stock's GF Value™ is €0.14, compared to a current price of €0.16 — trading 14.3% above its estimated fair value. The current Other Gross PPE is €0.0 Mil. Viva Biotech Holdings' overall GF Score™ is 43/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Gross PPE calculated?
Other Gross PPE is calculated from a company's financial statements. For Viva Biotech Holdings (FRA:VB0), the current Other Gross PPE is €0.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Viva Biotech Holdings (FRA:VB0) Overvalued in 2026?

Based on GuruFocus' analysis, Viva Biotech Holdings stock appears to be overvalued. The current stock price of €0.16 is trading 14.3% above its estimated GF Value™ of €0.14. GuruFocus considers Viva Biotech Holdings to be Modestly Overvalued.

Key valuation signals for FRA:VB0:

  • Other Gross PPE: €0.0 Mil
  • GF Value™: €0.14 vs. price of €0.16 (14.3% above fair value)
  • GF Score™: 43/100 with 5 warning signs

No single metric tells the full story. See the FRA:VB0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Viva Biotech Holdings Business Description

Other Exchanges VBIZF:USA01873:Hong Kong
Address 735 Ziping Road, Pudong New District, Zhoupu Town, Shanghai, CHN, 201318
Viva Biotech Holdings is engaged in providing the structure-based drug discovery services to biotechnology and pharmaceutical customers for their pre-clinical stage drug development. The company operates in three reportable segments, Drug Discovery Services providing structure-based drug discovery services to biotechnology and pharmaceutical customers for their pre-clinical stage drug development; Contract Development Manufacture Organisation providing contract development and manufacturing services for small molecule APIs and intermediates and trading of APIs, intermediates and formulations; and commercialisation services; and Viva BioInnovator making strategic investments in biotechnology startup companies.
43GF Score

Get the complete analysis for FRA:VB0

Other Gross PPE is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.16
Price
€0.14
GF Value